| Monument Health Custer Care Center | |
| 1065 Montgomery St, Custer, South Dakota 57730 | |
| (605) 673-2237 | |
| Name | Monument Health Custer Care Center |
|---|---|
| Location | 1065 Montgomery St, Custer, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 76 |
| Occupancy Rate | 47.37% |
| Medicare ID (CCN) | 435032 |
| Legal Business Name | Monument Health Network Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1386640126 |
| Organization Name | MONUMENT HEALTH NETWORK. INC. |
| Doing Business As | MONUMENT HEALTH CUSTER CARE CENTER |
| Address | 1065 Montgomery St, Custer, SD 57730 |
| Phone Number | 605-673-2237 |
News Archive
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.
Sen. Tom Coburn, a member of the Senate Gang of Six negotiations, and Rep. Chris Van Hollen, newly named to the Biden budget talks by House Minority Leader Nancy Pelosi, disagreed starkly on whether the debt ceiling increase needs to be tied to a budget deal. Coburn said he supports the budget proposed by House Budget Commiteee Chairman Paul Ryan which turns Medicare into a type of voucher system, saying that consumer choice is needed to drive prices down.
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States.
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.
Sen. Tom Coburn, a member of the Senate Gang of Six negotiations, and Rep. Chris Van Hollen, newly named to the Biden budget talks by House Minority Leader Nancy Pelosi, disagreed starkly on whether the debt ceiling increase needs to be tied to a budget deal. Coburn said he supports the budget proposed by House Budget Commiteee Chairman Paul Ryan which turns Medicare into a type of voucher system, saying that consumer choice is needed to drive prices down.
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States.
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $88197 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.69 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.22 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.48 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.52 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.19 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.58 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 86.63 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.87 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.89 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.78 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.05 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.46 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 18.99 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.91 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.32 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 68.48 | 82.93 |
News Archive
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.
Sen. Tom Coburn, a member of the Senate Gang of Six negotiations, and Rep. Chris Van Hollen, newly named to the Biden budget talks by House Minority Leader Nancy Pelosi, disagreed starkly on whether the debt ceiling increase needs to be tied to a budget deal. Coburn said he supports the budget proposed by House Budget Commiteee Chairman Paul Ryan which turns Medicare into a type of voucher system, saying that consumer choice is needed to drive prices down.
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States.
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
› Verified 3 days ago
Monument Health Custer Care Center Location: 1065 Montgomery St, Custer, South Dakota 57730 Phone: (605) 673-2237 |